fda glp-1 compounding enforcement news october 2025 New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our Compound versions of GLP-1 drugs
Description
Adults aged18 years with diabetes prescribed biguanides were included

Among the individual GLP-1RAs assessed, the largest reductions in CV risk, HbA1c, and weight outcomes were observed with combination therapy with SGLT2i and once weekly semaglutide for T2D
Experts weigh in on the rising trend of microdosing Ozempic and Wegovy.
This podcast is for informational purposes only and is not intended to replace professional medical advice.If you have a question for Dr